The trademark application CODRP was filed by MBD Co., Ltd., a corporation established under the laws of the Republic of Korea (the "Applicant"). The application was published for oppositions on June 16, 2022, and it was registered by office on September 23, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 10 with following description of goods:
Medical measuring device for cancer diagnosis
Cancer diagnosis kit
Medical measuring device for testing to predict anticancer drug sensitivity
Test kit for predicting anticancer drug sensitivity
Test tools for predicting anti-cancer drug sensitivity
Medical measuring device for testing to predict radiation sensitivity for medical use
Test kit for predicting radiation sensitivity for medical use
Test tools for predicting radiation sensitivity for medical use
Diagnostic kit for medical experiments
Clinical diagnostic kit.
The mark was filed in class 42 with following description of goods:
Genetic testing for scientific research purposes
DNA analysis for scientific research purposes
Research related to biotechnology
Cancer research
Medical scientific research in the field of cancer disease
Medical scientific research
Clinical laboratory.
The mark was filed in class 44 with following description of goods:
Medical analysis for cancer diagnosis and prognosis
Information provider in the field of cancer prevention/test/diagnosis/treatment
Medical test for diagnosis or treatment
Medical analysis for predicting anticancer drug sensitivity
Medical analysis for predicting radiation sensitivity for medical use.